This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Implied Volatility Surging for Guardian Pharmacy Services Stock Options
by Zacks Equity Research
Investors need to pay close attention to Guardian Pharmacy Services stock based on the movements in the options market lately.
medical medical-devices
4 PEG-Based GARP Picks for Navigating Early-2026 Market Uncertainty
by Urmimala Biswas
PAHC and others highlight how PEG-based GARP picks blend value and growth as markets hit 2026 highs amid rate uncertainty and valuation sensitivity.
basic-materials consumer-discretionary medical medical-devices
BFLY to Extend 3D Imaging Capabilities to Butterfly Garden Developers
by Zacks Equity Research
Butterfly Network targets a 2026 Beam Steering API, opening core imaging to developers and enabling AI tools in Butterfly Garden.
medical medical-devices
ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves
by Zacks Equity Research
AngioDynamics reports flat Q2 earnings while revenue increase 8.8% and gross margin expands 170 bps on stronger Med Tech performance.
earnings medical medical-devices
Here's Why You Should Add PacBio Stock to Your Portfolio
by Zacks Equity Research
PACB is gaining from product development and strong Q3 results, with Revio and Vega driving growth, though longer purchasing cycles remain a risk.
medical medical-devices
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now?
by Indrajit Bandyopadhyay
ISRG trades just 4% below its record high after a 32% surge over the past three months, driven by strong procedure growth, rising utilization, and early traction for the da Vinci 5 system.
medical medical-devices
5 Highly Efficient Stocks That Stand Out on Key Profitability Ratios
by Santanu Roy
United Natural Foods leads a screen of five efficient stocks that beat peers on key ratios, highlighting names investors may consider for stronger returns.
computers consumer-staples finance internet medical-devices
IDEXX Stock Up 64.7% in a Year: What's Driving the Growth?
by Zacks Equity Research
IDXX shares surge 64.7% in a year as CAG Diagnostics momentum, strong retention and expanding software adoption fuel growth across regions.
medical medical-devices
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection
by Zacks Equity Research
Ceribell wins FDA Breakthrough status for its AI-driven EEG solution to detect and monitor LVO strokes in hospitals, boosting credibility and growth outlook.
medical medical-devices